ARCELLX, INC. logo

ARCELLX, INC. Share Price ACLX

$115.07

▲

0.04

(0.03%)

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 27 Apr 2026

Check the interactive ARCELLX, INC. Stock chart to analyse performance

ARCELLX, INC. Key Stats

Check ARCELLX, INC. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$115.03
Open
$115.04
Market Capitalization
$6.7B
Today's Volume
$16.1M
Revenue TTM
$22.3M
EBITDA
$-246.4M
Earnings Per Share (EPS)
$-4.07
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-53.42%

Global Institutional Holdings in ARCELLX, INC.

  • Name

    Holdings %

  • T. Rowe Price Investment Management,Inc.

    27.73%

  • T. Rowe Price Investment Management,Inc.

    10.86%

  • Paradigm Biocapital Advisors LP

    9.79%

  • Vanguard Group Inc

    6.98%

  • FMR Inc

    6.09%

  • BlackRock Inc

    5.79%

Analyst Recommendation on ARCELLX, INC. Stock

Rating
Trend

Buy

    95%Buy

    4%Hold

    0%Sell

Based on 21 Wall street analysts offering stock ratings for ARCELLX, INC.(by analysts ranked 0 to 5 stars)

About ARCELLX, INC.

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company preclinical product includes ACLX-004 for the treatment of AML and MDS. Further, the company focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize nito-cel and next-generation autologous and non-autologous CAR-T cell therapy products. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Organization
ARCELLX, INC.
Employees
209
CEO
Mr. Rami Elghandour
Industry
Healthcare

Key Management of ARCELLX, INC.

NameTitle
Mr. Rami Elghandour
Chairman of the Board, CEO & President
Ms. Michelle Lim Gilson
Chief Financial Officer
Ms. Aileen Fernandes
Chief Operating Officer
Mr. Narinderjeet Singh M.S.
Chief Technical Officer
Dr. Heba Nowyhed Ph.D.
Chief Scientific Officer
Ms. Myesha Lacy
Chief Investor & Communications Officer
Ms. Maryam Abdul-Kareem J.D., M.S.
General Counsel & Chief Legal Officer
Ms. Kate Aiken
Chief People Officer
Mr. Neeraj P. Teotia
Chief Commercial Officer
Ms. Helen Kim
VP & Head of Regulatory Affairs

Important FAQs about investing in ACLX Stock from India :

What is ARCELLX, INC. share price today?

ARCELLX, INC. share price today is $115.07 as on at the close of the market. ARCELLX, INC. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for ARCELLX, INC. share?

ARCELLX, INC. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. ARCELLX, INC. stock price today i.e. is closed at $115.07, lower by 0.05% versus the 52 week high.

How to invest in ARCELLX, INC. Stock (ACLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ARCELLX, INC. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ARCELLX, INC. Shares that will get you 0.0130 shares as per ARCELLX, INC. share price of $115.07 per share as on April 27, 2026 at 12:00 am IST.

What is the minimum amount required to buy ARCELLX, INC. Stock (ACLX) from India?

Indian investors can start investing in ARCELLX, INC. (ACLX) shares with as little as ₹94.42 or $1 (as of June 21, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹944.20 in ARCELLX, INC. stock (as per the Rupee-Dollar exchange rate as on June 21, 2026). Based on ARCELLX, INC. share’s latest price of $115.07 as on April 27, 2026 at 12:00 am IST, you will get 0.0869 shares of ARCELLX, INC.. Learn more about fractional shares .

What are the returns that ARCELLX, INC. has given to Indian investors in the last 5 years?

ARCELLX, INC. stock has given 0.0% share price returns and 27.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?